%A Jahan, Hasna %A Yeasmin, Tanzima %A Roy, Molay %D 2022 %T Elevated D-dimer is associated with severity of COVID-19: A systematic review and meta-analysis %K %X With the rapid increase of COVID-19 cases, identifying case severity has become a critical issue for hospital admission and intensive care treatment. Given that pre-existing comorbidities play a significant role in the severity, emerging evidence indicates coagulopathy becomes an independent condition that causes respiratory distress in COVID-19. In this metanalysis, relevant literatures reporting D-dimer, a coagulation byproduct, in COVID-19 cases were synthesized and statistically analyzed to test if the D-dimer level can predict case severity and mortality. The analysis found that D-dimer levels were higher in non-survivors/severe than in survivors/non-severe, (MD 0.64, 95% CI 0.52 to 0.75; participants = 5957, I 2 = 98%). Subgroup analysis showed MD between non-survivors and survivors was MD 3.48 μg/mL (95% CI 2.69 to 4.27; participants = 1799; studies = 7; I 2 = 86%) with Z-score 8.64, p<0.0001. In meta-regression, a significant correlation was observed between increased plasma mean D-dimer level with increased proportion case severity ( P =0.046) and mortality ( P =0.009). Overall, the study found that the D-dimer level index can be a predictor of risk for case severity and mortality in COVID-19 patients. The test is rapid and inexpensive and can help clinicians prioritize medical care other than deciding therapeutic options for clinical goals. %U https://esmed.org/MRA/mra/article/view/2870 %J Medical Research Archives %0 Journal Article %R 10.18103/mra.v10i7.2870 %V 10 %N 7 %@ 2375-1924 %8 2022-07-31